Table 5.
Hierarchy of Recommended Oral Antibiotics for EOS by Silo (ie Susceptibility of S. aureus)
| Silo | Recommended Oral Antibiotic According to Allocated Backbone Domain | |||||
|---|---|---|---|---|---|---|
| Adult | Pregnancy | Pediatric | ||||
| PSSA | Benzylpenicillin | (Flu)cloxacillin | Benzylpenicillin | (Flu)cloxacillin | Benzylpenicillin | (Flu)cloxacillin |
|
|
|
|
|
|
|
| MSSA | (Flu)cloxacillin | Cefazolin | (Flu)cloxacillin | Cefazolin | (Flu)cloxacillin | Cefazolin |
|
|
|
|
|
|
|
| MRSA | Vancomycin/daptomycin | Vancomycin/daptomycin + cefazolin | Vancomycin/daptomycin | Vancomycin/daptomycin + cefazolin | Vancomycin/daptomycin | Vancomycin/daptomycin + cefazolin |
|
|
|
|
|
|
|
Site PIs and treating clinicians are encouraged, but not mandated, to select the highest antibiotic on this list which is appropriate for a given patient.
Abbreviations: EOS, early oral switch; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin- susceptible Staphylococcus aureus; PSSA, penicillin-susceptible Staphylococcus aureus; TMP-SMX, trimethoprim-sulfamethoxazole.
aTMP-SMX only suitable during the second trimester. Avoid in first and third trimester.